Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Sabran J. Masoud"'
Autor:
Qichen Chen, Kan Li, Kristen E. Rhodin, Sabran J. Masoud, Michael E. Lidsky, Jianqiang Cai, Qingyi Wei, Sheng Luo, Hong Zhao
Publikováno v:
Journal of Surgical Oncology. 127:945-955
Autor:
Sabran J. Masoud, Sabino Zani, Dan G. Blazer, Kevin N. Shah, Megan C. Turner, James L. Abbruzzese, Marcelo Cerullo, Mohamed A. Adam
Publikováno v:
HPB. 22:1542-1548
Adjuvant chemotherapy (AC) is associated with improved survival following resection of pancreatic adenocarcinoma but is frequently delayed or deferred due to perioperative complications or patient deconditioning. The aim of this study was to assess i
Autor:
Sabran J. Masoud, Cara O'Brien, Oliver K. Jawitz, Larissa G. Rodriguez-Homs, Paul J. Mosca, Matthew J. Mosca
Publikováno v:
Journal for healthcare quality : official publication of the National Association for Healthcare Quality. 43(6)
This retrospective, cross-sectional study of U.S. hospitals in Medicare's Inpatient Quality Reporting Program aimed to determine whether variation in Sepsis/Septic Shock (Bundle SEP-1) compliance is linked to hospital size and measures of safety and
Publikováno v:
Immunotherapy. 12(16)
Aim: Talimogene laherparepvec (T-VEC) is a genetically modified oncolytic herpesvirus approved for the treatment of unresectable, locoregionally advanced and recurrent melanoma. There is little relevant literature in the context of retreatment with T
Autor:
Larissa G. Rodriguez-Homs, Paul J. Mosca, Sabran J. Masoud, Kathryn C. Adair, J. Bryan Sexton
Publikováno v:
Journal of Medical Internet Research, Vol 22, Iss 5, p e15562 (2020)
Journal of Medical Internet Research
Journal of Medical Internet Research
Background Emotional exhaustion (EE) in health care workers is common and consequentially linked to lower quality of care. Effective interventions to address EE are urgently needed. Objective This randomized single-exposure trial examined the efficac
Autor:
Norma E. Farrow, Douglas S. Tyler, Sabran J. Masoud, Jennifer A. Perone, Paul J. Mosca, Georgia M. Beasley
Publikováno v:
Current Treatment Options in Oncology. 20
The original version of this article, which published in Current Treatment Options in Oncology, Volume 19, Issue 11, November 2018, contained an error within the Conflict of Interest statements. It was originally stated that "Norma E. Farrow received
Publikováno v:
Annals of surgical oncology. 26(13)
Talimogene laherparepvec (T-VEC) is the first injectable oncolytic viral therapy approved for in-transit melanoma metastasis, with a reported overall response rate (ORR) of 25% and complete response rate (CRR) of 10%. To ascertain the role of patient
Autor:
Larissa G. Rodriguez-Homs, Sabran J. Masoud, Oliver K. Jawitz, Harry R. Phillips, Paul J. Mosca
Publikováno v:
Abstracts.
Background Improved discharge planning has been implicated in reducing post-operative complications. Readmissions and mortality after coronary artery bypass grafting (CABG) are two procedure-specific complications Medicare publicly reports. While pat
Autor:
Sabran J. Masoud, Cara O'Brien, Larissa G. Rodriguez-Homs, Harry R. Phillips, Paul J. Mosca, Oliver K. Jawitz
Publikováno v:
Abstracts.
Background In 2018, Medicare began public reporting of hospital compliance with Sepsis and Septic Shock Early Management (SEP-1) bundle. We queried whether a relationship between SEP-1 bundle compliance, hospital size, and global measures of quality
Autor:
Sabran J. Masoud, Paul J. Mosca, Norma E. Farrow, Douglas S. Tyler, Jennifer A. Perone, Georgia M. Beasley
Publikováno v:
Current treatment options in oncology. 19(11)
This review critically evaluates recent trials which have challenged the practice of completion lymph node dissection (CLND) for melanoma patients diagnosed with regional metastasis by positive sentinel lymph node biopsy (SLNB). Two trials in the las